From: Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada
Case | Age | Sex | HAE Type | Comorbidities | Other medications | Age symptom onset (years) | Age HAE diagnosis (years) |
---|---|---|---|---|---|---|---|
1 | 25 | M | 1 | Nil | Nil | 18 | 18 |
2 | 24 | M | 1 | Nil | Nil | 1 | 4 |
3 | 42 | F | 1 | SLE (quiescent) | Nil | 10 | 23 |
4 | 38 | F | 2 | Nil | Nil | 11 | 2 |
5 | 36 | F | 1 | Ulcerative Colitis | Nil | 4 | 12 |
6 | 30 | F | 1 | GERD, Chronic Pain | Methadone | 23 | 25 |
7 | 59 | F | 1 | Nil | Nil | 26 | 59 |
8 | 34 | F | 1 | Depression | Citalopram | 11 | 11 |
9 | 50 | F | 1 | Nil | Nil | 47 | 48 |
10 | 74 | F | 1 | Multiple Myeloma, HTN | Revlimid, Telmisartan | Unknown | 55 |
11 | 44 | F | 1 | Raynaud’s, GERD, Cervical Stenosis | Esomeprazole | 15 | 33 |
12 | 65 | M | 1 | T1DM, Primary Adrenal Insufficiency | Insulin Pantoprazole | 37 | 37 |